Skip to main content

Prototype Prescribing Outlier Dashboard for Glebedale Medical Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Glebedale Medical Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Etonogestrel 26 Parenteral progestogen-only contraceptives 26 1.00 0.12 0.15 5.72
Ketotifen fumarate 12 Other anti-inflammatory preparations 70 0.17 0.02 0.04 3.86
Acetylcysteine 255 Mucolytics 827 0.31 0.02 0.08 3.61
Varenicline tartrate 2 Nicotine dependence 2 1.00 0.18 0.24 3.35
Lacidipine 782 Calcium-channel blockers 7,579 0.10 0.01 0.03 3.34
Acarbose 41 Other antidiabetic drugs 2,513 0.02 0.00 0.00 3.05
Betamethasone valerate 416 Topical corticosteroids 889 0.47 0.28 0.07 2.78
Mycophenolic sodium 6 Antiproliferative immunosuppressants 83 0.07 0.01 0.03 2.58
Dequalinium chloride 1 Vaginal and vulval infections 75 0.01 0.00 0.01 2.45
Nebivolol 366 Beta-adrenoceptor blocking drugs 6,504 0.06 0.02 0.02 2.36

Prescribing where Glebedale Medical Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Medroxyprogesterone acetate 0 Parenteral progestogen-only contraceptives 26 0.00 0.88 0.15 -5.72
    Carbocisteine 563 Mucolytics 827 0.68 0.97 0.08 -3.49
    Nicotine 0 Nicotine dependence 2 0.00 0.65 0.33 -1.95
      Letrozole 11 Breast cancer 364 0.03 0.45 0.22 -1.93
      Ketoconazole 26 Shampoos and some other scalp preparations 107 0.24 0.50 0.15 -1.67
      Lymecycline 42 Tetracyclines 738 0.06 0.24 0.12 -1.59
      Docusate sodium 34 Stimulant laxatives 730 0.05 0.25 0.14 -1.48
      Combined ethinylestradiol 30mcg 152 Combined hormonal contraceptives 215 0.71 0.81 0.07 -1.44
      Zinc oxide 2 Barrier preparations 41 0.05 0.49 0.33 -1.35
      Hydrocortisone 229 Topical corticosteroids 889 0.26 0.34 0.06 -1.30